ArticleToxics2026
Machine Learning Prediction of Transthyretin Binding for Thyroid Hormone Transport Disruption for Chemical Risk Assessment.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endocrine-Disrupting Chemicals (EDCs) disrupt thyroid hormone (TH) synthesis, transport, metabolism, and action, thereby perturbing systemic endocrine homeostasis. Transthyretin (TTR) is a key TH transport protein that regulates circulating hormone distribution and tissue availability, particularly during critical developmental windows. Chemical interference with TTR-binding may alter TH bioavailability and represent a transport-mediated molecular initiating event within thyroid-axis perturbation. Despite widespread exposure, many thyroidal EDCs remain unidentified, and their health effects are difficult to assess due to multiple simultaneous exposures. To support endocrine hazard identification and chemical prioritization within risk assessment frameworks, we developed machine learning-based QSAR models during the Tox24 challenge, using a dataset of 1512 chemicals to predict TTR-binding affinity. Of these, 67% were used for training, 13% for testing, and 20% for validation. Molecular descriptors were selected by first removing highly correlated features and then ranking the remaining descriptors using mutual information regression. The leverage approach was applied to define the models' applicability domain (AD). Five machine learning algorithms, including gradient boosting regressor (GBR), Random Forest, Lasso Regression, Support Vector Machine (SVM), and regularized SVM models, were developed. The GBR model demonstrated the best overall performance. This model achieved an
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.